UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Recruitment of the Earliest Component of the Bacterial Flagellum to the Old Cell Division Pole by a Membrane-Associated Signal Recognition Particle Family GTP-Binding Protein

Journal of molecular biology, 2009-08, Vol.391 (4), p.679-690

2009

Volltextzugriff (PDF)

Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy

Current oncology (Toronto), 2023-05, Vol.30 (6), p.5299-5308

2023

Volltextzugriff (PDF)

Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing

Current oncology (Toronto), 2022-11, Vol.29 (11), p.8686-8692

2022

Volltextzugriff (PDF)

Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world

Cancer medicine (Malden, MA), 2022-01, Vol.11 (1), p.86-93

2022

Volltextzugriff (PDF)

Cell Death and Mechanoprotection by Filamin A in Connective Tissues after Challenge by Applied Tensile Forces

The Journal of biological chemistry, 2002-06, Vol.277 (24), p.21998-22009

2002

Volltextzugriff (PDF)

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Clinical cancer research, 2021-01, Vol.27 (1), p.202-212

2021

Volltextzugriff (PDF)

Molecular testing in non-small cell lung cancer: a snapshot of The Royal Free London NHS Foundation Trust experience

Lung cancer (Amsterdam, Netherlands), 2021-06, Vol.156, p.S38

2021

Volltextzugriff (PDF)

The efficacy of crizotinib in patients with -positive nonsmall cell lung cancer

Therapeutic advances in respiratory disease, 2015-06, Vol.9

2015

Volltextzugriff (PDF)

Confirmation of germline variants identified by tumor testing: A population-based study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e13021-e13021

2019

Volltextzugriff (PDF)

Lung Cancer in Canada

Journal of thoracic oncology, 2019-07, Vol.14 (7), p.1128-1133

2019

Volltextzugriff (PDF)

Intratumoral heterogeneity in programmed death‐ligand 1 immunoreactivity is associated with variation in non‐small cell lung carcinoma histotype

Histopathology, 2020-02, Vol.76 (3), p.394-403

2020

Volltextzugriff (PDF)

An audit of the management of Staphylococcus aureus bloodstream infections over two years in a District General Hospital in the United Kingdom: Category: Clinical lesson

The Journal of infection, 2011-12, Vol.63 (6), p.e78-e78

2011

Volltextzugriff (PDF)

Olaratumab for the treatment of soft-tissue sarcoma

Future oncology (London, England), 2017-10, Vol.13 (24), p.2151-2157

2017

Volltextzugriff (PDF)

Quantification of circulating free and circulating tumor DNA in pretreated EGFR mutant NSCLC to inform patient outcomes

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9080-9080

2019

Volltextzugriff (PDF)

Abstract 1647: CAPTIV-8: A prospective trial of atezolizumab using a multivariate model incorporating whole genome and transcriptome analysis

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1647-1647

2021

Volltextzugriff (PDF)

The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer

Therapeutic Advances in Respiratory Disease, 2015-06, Vol.9 (3), p.97-104

2015

Volltextzugriff (PDF)

The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space

The Journal of molecular diagnostics : JMD, 2022-06, Vol.24 (6), p.609-618

2022

Volltextzugriff (PDF)

Imaging-Guided Palliative Procedures: Tendon and Bursa Injection

Interventional Radiology in Palliative Care, p.59-70

Volltextzugriff (PDF)

EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes

Translational lung cancer research, 2020-08, Vol.9 (4), p.1084-1092

2020

Volltextzugriff (PDF)

Abstract 2408: A novel multiplex droplet digital PCR approach to KRAS mutation detection in circulating tumor DNA

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2408-2408

2015

Volltextzugriff (PDF)

Simultaneous EGFR mutation detection and copy number assessment in circulating tumour DNA (ctDNA) to inform molecular methods of therapy resistance and plasma ctDNA content in lung adenocarcinoma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e23027-e23027

2016

Volltextzugriff (PDF)

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Blood advances, 2024-02, Vol.8 (4), p.878-888

2024

Volltextzugriff (PDF)

Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood

Immunotherapy advances, 2023-01, Vol.3 (1), p.ltad001-ltad001

2023

Volltextzugriff (PDF)

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach: e0139074

PloS one, 2015-09, Vol.10 (9)

2015

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(26)
Buchkapitel
(4)

Sprache

Englisch
(30)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(10)
Oncology
(8)
Immunotherapy
(4)
Mutation
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(3)
Chemotherapy
(3)
Lung Cancer
(3)
Respiratory System
(3)
Adult
(2)
Animals
(2)
Apoptosis
(2)
B7-H1 Antigen - Metabolism
(2)
Biochemistry & Molecular Biology
(2)
Canada
(2)
Cancer
(2)
Cancer Therapies
(2)
Cell Membrane - Metabolism
(2)
Clinical Trials As Topic
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Recruitment of the Earliest Component of the Bacterial Flagellum to the Old Cell Division Pole by a Membrane-Associated Signal Recognition Particle Family GTP-Binding Protein

Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy

Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing

Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world

Cell Death and Mechanoprotection by Filamin A in Connective Tissues after Challenge by Applied Tensile Forces

Genome and Transcriptome Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

Molecular testing in non-small cell lung cancer: a snapshot of The Royal Free London NHS Foundation Trust experience

The efficacy of crizotinib in patients with -positive nonsmall cell lung cancer

Confirmation of germline variants identified by tumor testing: A population-based study

Lung Cancer in Canada

Intratumoral heterogeneity in programmed death‐ligand 1 immunoreactivity is associated with variation in non‐small cell lung carcinoma histotype

An audit of the management of Staphylococcus aureus bloodstream infections over two years in a District General Hospital in the United Kingdom: Category: Clinical lesson

International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence Variant

Olaratumab for the treatment of soft-tissue sarcoma

Quantification of circulating free and circulating tumor DNA in pretreated EGFR mutant NSCLC to inform patient outcomes

Abstract 1647: CAPTIV-8: A prospective trial of atezolizumab using a multivariate model incorporating whole genome and transcriptome analysis

The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer

The Neoantigen Landscape of the Coding and Noncoding Cancer Genome Space

Imaging-Guided Palliative Procedures: Tendon and Bursa Injection

EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomes

Abstract 2408: A novel multiplex droplet digital PCR approach to KRAS mutation detection in circulating tumor DNA

Simultaneous EGFR mutation detection and copy number assessment in circulating tumour DNA (ctDNA) to inform molecular methods of therapy resistance and plasma ctDNA content in lung adenocarcinoma

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach: e0139074

Aktive Filter

Suchergebnisse filtern